BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 9764612)

  • 1. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
    Moosig F; Csernok E; Wang G; Gross WL
    Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.
    Steiner K; Moosig F; Csernok E; Selleng K; Gross WL; Fleischer B; Bröker BM
    Clin Exp Immunol; 2001 Oct; 126(1):143-50. PubMed ID: 11678911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease.
    Liu ZX; Hiwatashi N; Noguchi M; Toyota T
    Scand J Gastroenterol; 1997 Dec; 32(12):1241-6. PubMed ID: 9438323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of costimulatory molecules in myasthenia gravis.
    Teleshova N; Matusevicius D; Kivisäkk P; Mustafa M; Pirskanen R; Link H
    Muscle Nerve; 2000 Jun; 23(6):946-53. PubMed ID: 10842273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
    Martínez-Escribano JA; Hernández-Caselles T; Campillo JA; Campos M; Frías JF; García-Alonso A; Alvarez-López MR
    Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human inducible costimulator ligand expression and function.
    Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
    J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
    Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
    Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
    Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
    Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the costimulator molecules, CD80, CD86, CD28, and CD152 on lymphocytes from neonates and young children.
    Elliott SR; Macardle PJ; Roberton DM; Zola H
    Hum Immunol; 1999 Nov; 60(11):1039-48. PubMed ID: 10600000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process.
    Agostini C; Trentin L; Perin A; Facco M; Siviero M; Piazza F; Basso U; Adami F; Zambello R; Semenzato G
    Am J Physiol; 1999 Aug; 277(2):L240-50. PubMed ID: 10444517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
    Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
    Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory molecules in human periodontal disease tissues.
    Gemmell E; McHugh GB; Grieco DA; Seymour GJ
    J Periodontal Res; 2001 Apr; 36(2):92-100. PubMed ID: 11327084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis.
    Lamprecht P; Moosig F; Csernok E; Seitzer U; Schnabel A; Mueller A; Gross WL
    Thorax; 2001 Oct; 56(10):751-7. PubMed ID: 11562512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
    Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
    Behar SM; Porcelli SA; Beckman EM; Brenner MB
    J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.